June 11, 2018
On June 11, 2018, Salk’s Board of Trustees met to discuss the findings of the Institute’s investigation into allegations against Dr. Inder Verma. Our commitment from the outset has been to undertake an investigatory process that is thorough and impartial and to take action as appropriate. Although we will not comment on the details of this confidential personnel matter, we wanted to share with you the outcome of this process.
Based on the findings of the investigator, the Institute has considered appropriate responsive action. Last week, prior to the board concluding its discussions regarding the investigation and taking formal action, Dr. Verma tendered his unconditional resignation. This morning, the Board of Trustees voted unanimously to accept it.
As we have acknowledged, this has been a challenging time for the Institute. We have been heartened by the way the Salk community has come together and worked together to face these challenges.
When we signed on to be part of the Salk, we signed on to Jonas Salk’s bold mission to better humanity. And no humanistic value can be more important than respectful, fair treatment of each and every person – not just on our campus, but in all walks of our lives.
Sincerely,
Dan Lewis, Chair, Board of Trustees
Rusty Gage, President
Oficina de Comunicaciones
Tel.: (858) 453-4100
press@salk.edu
El Instituto Salk es un centro de investigación independiente y sin fines de lucro fundado en 1960 por Jonas Salk, creador de la primera vacuna segura y eficaz contra la poliomielitis. La misión del Instituto es impulsar una investigación fundamental, colaborativa y audaz que aborde los retos más acuciantes de la sociedad, entre ellos el cáncer, la enfermedad de Alzheimer y la vulnerabilidad agrícola. Esta ciencia fundamental sustenta todos los esfuerzos traslacionales, generando conocimientos que permiten el desarrollo de nuevos medicamentos e innovaciones en todo el mundo.
